statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Virios Therapeutics, Inc. (NASDAQ:VIRI - Get Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 170,200 shares, a growth...

Virios Therapeutics, Inc. (NASDAQ:VIRI) Sees Significant Growth in Short Interest

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Virios Therapeutics announces publication of international patent for IMC-2

- New patent would extend coverage and expand potential value of Virios' antiviral pipeline globally - Active Long-COVID characterized by immune dysfunction leading to recurrent herpesviruses...

Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID

Gagnants
Le titre IMAC Hldgs (NASDAQ:BACK) a augment vendredi de 96,12% 2,53 dollars lors de la session ordinaire.
L'action Ontrak (NASDAQ:OTRK) a grimp de 34,65% 0,35 dollars.
Le titre Virios...

12 titres de soins de sant  en mouvement lors de la session du 22/03/2024

Virios Therapeutics, Inc. (NASDAQ:VIRI  Get Free Report) was the target of a significant drop in short interest during the month of February. As of February 29th, there was short interest...

Virios Therapeutics, Inc. (NASDAQ:VIRI) Short Interest Update

ATLANTA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the Company ), a development-stage biotechnology company focused on advancing novel antiviral therapies to...

Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

ATLANTA, Ga., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the Company ), a development-stage biotechnology company focused on advancing novel antiviral therapies to...

Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones

- Placebo-Controlled Clinical Proof of Concept Data Expected in Mid-2024 -- Targeting Initiation of IMC-2 Phase 2 program in 2H 2024 - ATLANTA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Virios...

Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID

Virios Therapeutics, Inc. (NASDAQ:VIRI  Get Free Report)s stock price traded down 8.3% on Wednesday . The company traded as low as $0.53 and last traded at $0.53. 257,149 shares were...

Virios Therapeutics (NASDAQ:VIRI)  Shares Down 8.3%

ATLANTA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the Company ), a development-stage biotechnology company focused on developing novel antiviral therapies to...

Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID

Virios Therapeutics, Inc. engages in pharmaceutical products for fibromyalgia and other related conditions. The firm engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1, a novel, proprietary, fixed dose combination of famciclovir and celecoxib. The company was founded by William L. Pridgen on February 28, 2012 and is headquartered in Alpharetta, GA.

Volume	27,579.00
52-Wk High	$2.42
52-Wk Low	$0.279

VIRI Virios Therapeutics Inc

About

Feed

News

Earnings

Fundamentals